Comparing Mentalization-Based Treatment and Standard Therapy for Borderline Personality Disorder in Germany
Official title: Mentalisierungsbasierte Therapie Versus Bona-fide-Therapie für Patient:Innen Mit Borderline-Persönlichkeitsstörung in Deutschland (MaGnet): Eine Prospektive, Multizentrische Randomisiert-kontrollierte Studie Mentalization-based Treatment Versus Bona-fide Treatment for Patients With Borderline Personality Disorder in Germany (MAGNET): a Prospective, Multi-centre Randomized Controlled Trial
Run by Heidelberg University · NCT06018272 · Data updated 2026-11-12
This study is testing if a new type of therapy called Mentalization-Based Treatment can help people with Borderline Personality Disorder in Germany feel better and have fewer crises compared to standard therapy options.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 304 (estimated) |
| Sponsor | Heidelberg University Academic / other |
| Locations | 5 sites (Berlin and 4 other locations) |
| Status | Recruiting |
| Started | February 28, 2024 |
| Main results expected | September 30, 2027 |
| Study ends | March 31, 2028 |
| Registry record updated | May 10, 2024 |
| Trial ID | NCT06018272 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with Borderline Personality Disorder who have experienced non-suicidal self-injury or suicide attempts in the past two years.
✕Probably not a fit
Patients with acute substance use disorders (except cannabis dependency), schizophrenia, bipolar I disorder, or significant cognitive impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of Mentalization-Based Treatment (MBT) compared to bona fide treatments (BFT) such as psychodynamic or cognitive-behavioral psychotherapy for patients with Borderline Personality Disorder (BPD) in Germany. The study aims to determine if MBT can more effectively reduce crisis events, including non-suicidal self-injury and suicide attempts, while also assessing its impact on overall functioning, symptom severity, and cost-effectiveness. Participants will be monitored for changes in their mental health and quality of life over the course of the treatment. This randomized-controlled trial addresses a significant gap in existing research on outpatient MBT in Germany.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for patients with Borderline Personality Disorder, potentially reducing self-harm and improving overall mental health outcomes.
How similar studies have gone: While there is limited research on MBT in outpatient settings in Germany, similar studies in other regions have shown promising results for MBT in treating BPD.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Borderline Personality Disorder * non-suicidal self injury or suicide attempts in the past two years as indicated by the IPDE item "repeated suicidal behaviours, gestures, threats or self-harm", one of which has occurred in the past six months Exclusion Criteria: * acute substance use disorder (exception: cannabis dependency) * diagnosis of schizophrenia or schizotypal personality disorder * bipolar I disorder (DSM-5) * cognitive impairment (IQ\<80) or evidence of organic brain disorder * BMI\<16.5 * serious medical condition that will require hospitalization within the next year (e.g. cancer) * no sufficient German language abilities
Where it's running
-
Psychologische Hochschule Berlin
Berlin, Germany Recruiting -
Heidelberg University
Heidelberg, Germany Recruiting -
Clinic for Psychosomatic Medicine and Psychotherapy, University Hospital Düsseldorf
Düsseldorf, Germany Not yet recruiting -
Institute for Psychosocial Medicine, Psychotherapy and Psychooncology
Jena, Germany Not yet recruiting -
Clinic for Psychosomatic Medicine and Psychotherapy, University Hospital Ulm
Ulm, Germany Not yet recruiting
Study contacts
- Principal investigator: Svenja Taubner — University Heidelberg
- Study coordinator: Svenja Taubner, Prof.
- Email: svenja.taubner@med.uni-heidelberg.de
- Phone: +496221564701
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Long-term outcomes after MBT for borderline personality disorder
This long-term follow-up checks how people with borderline personality disorder who received MBT in the past are doing more than 10 years later and whether the two MBT formats differ in long-term outcomes.
-
See if Borderline Personality Disorder can be viewed as a Relationship-Use Disorder
Researchers are testing whether BPD symptoms reflect an addiction-like reliance on interpersonal relationships, compared with bipolar disorder and healthy controls.
-
rTMS (noninvasive brain stimulation) for borderline personality disorder
This project will try rTMS brain stimulation to see if it reduces symptoms in adults with borderline personality disorder.
-
Evaluating a new treatment approach for borderline personality disorder
This study is testing a new personalized treatment for borderline personality disorder to see if it works better than the standard approach.
-
Physical activity for people with schizophrenia, borderline personality disorder, or vestibular disorders
This study tests whether a tailored physical activity program helps people with schizophrenia, borderline personality disorder, or vestibular disorders improve activity adherence and well‑being.
-
Training to improve emotion regulation in people with Borderline Personality Disorder
This study is testing a new training program to help people with Borderline Personality Disorder learn better ways to manage their emotions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.